How often are we told that a specific drug is wonderful and is therefore essential if a disease is to be treated successfully or to be prevented. The hard reality is that this begs an awful lot of questions and is only one minor...Read More
Readers of these blogs will be aware that there is very little reliable evidence to demonstrate that using statins to lower total cholesterol (TC) and LDL-Cholesterol (LDL-C) has substantial benefits. As a general rule, the...Read More
This is the title of a book just published, which describes and explains the science that justifies the conclusion (1). Equally important, it tells the story of why and how health professionals have been actively promoting a...Read More
The death was announced recently of Dr Duane Graveline, who established the Spacedoc website (1). Dr Graveline was a qualified MD and spent a period of his working life as an astronaut. During this time he was treated with...Read More
The recent spat between the BMJ and The Lancet about statins must leave the ordinary members of the public in a complete state of confusion. If the leaders of the medical professions cannot agree, what chance is there for the...Read More
I have lost count of the number of people who have been recommended to use statins but subsequently decided to stop taking them. There are two reasons normally used to justify these regimes, namely: You are at high risk of...Read More
Currently there is widespread use of statins which is justified on the grounds that those who receive regular treatment will have a reduced risk of developing heart disease. Ideally there should be thorough evaluations which...Read More
I have just discovered a fascinating paper which describes the results of gathering and collating information from self-reported accounts of adverse reactions to statins (1). It has been published on the internet by the Journal...Read More
A recent article in the BMJ highlighted concerns about the statin Crestor which in 2014 was the most prescribed brand name drug in the US, with 22.3 million prescriptions at a cost of $5.8bn. World-wide sales for 2013 were...Read More
One of the commonly used statins is rosuvastatin, which has the brand name Crestor and is produced by AstraXeneca. It was evaluated in the trial known as JUPITER, which has been subject to considerable criticism (1). In a review...Read More
- 306. Opioids
- 305. A Comparison between the approaches to Type 2 Diabetes (T2D) by Dr David Unwin and Diabetes UK
- 304. Sulphonylureas increase cardiac deaths but are still recommended for use after Metformin in type two diabetics in Scotland.
- 303. Statins: Why it is crucial to have a comprehensive picture
- 302. The Conventional Treatment of Type 2 Diabetes (T2D)
- @heatherybank @DietDoctor Ruth,
I haven't tried them myself. This article may offer some guidance.
about 20 hours ago
- Well done Daily Mail! It comes as a welcome change to the propaganda regurgitated on the BBC News. Absolutely no a… https://t.co/OPGhoXcaQJ
about 3 days ago
- @zoeharcombe Not for me!
"None of the trials..are designed to detect a reduction in any serious outcome such as hos… https://t.co/Jr0LYNdI2i
about 3 days ago
- @simondolan Precisely!
"None of the trials ..are designed to detect a reduction in any serious outcome such as hosp… https://t.co/8S2RXeWrdU
about 3 days ago
- "The main causes of cross-contamination are the way members of the public use the swab kits; contamination of the i… https://t.co/iBH2NncGuv
about 4 days ago